Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry

European Heart Journal

Volumn 37, Issue 31, 2016, Pages 2465-2474

  Boersma, Lucas V A ^a   Schmidt, Boris ^b   Betts, Timothy R ^c   Sievert, Horst ^d   Tamburino, Corrado ^e   Teiger, Emmanuel ^f   Pokushalov, Evgeny ^g   Kische, Stephan ^h   Schmitz, Thomas ⁱ   Stein, Kenneth M ^j   Bergmann, Martin W ^k  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d Department of Cardiology   (Germany)

^e Ospedale Ferrarotto Catania   (Italy)

^f HENRI MONDOR HOSPITAL   (France)

^g MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

^h VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

ⁱ ELISABETH KRANKENHAUS ESSEN   (Germany)

^j BOSTON SCIENTIFIC CORPORATION   (United States)

^k Department of Psychiatry and Psychotherapy   (Germany)

more..

Author keywords

Atrial fibrillation; Left atrial appendage; Stroke

Indexed keywords

ANTICOAGULANT AGENT; CLOPIDOGREL;

ABNORMAL LABORATORY RESULT; ADULT; AGED; AIR EMBOLISM; ANAPHYLAXIS; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BLOOD VESSEL INJURY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHA2DS2-VASC SCORE; CHADS2 SCORE; CONTROLLED STUDY; DEVICE EMBOLIZATION; FALSE ANEURYSM; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HAS-BLED SCORE; HEART ARREST; HEART FAILURE; HEART SURGERY; HEART TAMPONADE; HEMATOMA; HEMATURIA; HEMOPTYSIS; HUMAN; HYPOTENSION; INCIDENCE; LEFT ATRIAL APPENDAGE CLOSURE; LUNG DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MEDICAL DEVICE COMPLICATION; MITRAL VALVE REGURGITATION; MORTALITY RATE; MULTICENTER STUDY; PERICARDIAL EFFUSION; PERIPHERAL VASCULAR DISEASE; PHYSICAL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; REOPERATION; SAFETY; SCORING SYSTEM; SICK SINUS SYNDROME; SYSTEMC INFECTION; SYSTEMIC INFECTION; THORAX PAIN; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; VEIN LACERATION; ATRIAL FIBRILLATION; HEART ATRIUM APPENDAGE;

ANTICOAGULANTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; HUMANS; REGISTRIES; STROKE; TREATMENT OUTCOME;

EID: 85030433377     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv730     Document Type: Article

References (15)

1. Blackshear J, Odell J. Appendage obliteration to reduce stroke in cardiac surgical patients with AF. Ann Thorac Surg 1996;61:755–759.
2. Holmes DR, Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin J, Holmes D, on behalf of the PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009; 374:534–542.
3. Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of the WATCHMAN left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 2014;64:1–12.
4. Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N, Holmes D, for the PROTECT AF Steering Committee and Investigators. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 2014;312: 1988–1998.
5. Camm AJ, Lip GY, De Caterina S, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, ESC Committee for Practice Guidelines (CPG). 2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation: developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33:2719–2747.
6. Meier B, Blaauw Y, Khattab AA, Lewalter T, Sievert H, Tondo C, Glikson M. EHRA/ EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. EuroIntervention 2014;10:1109–1125.
7. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Juni P, Kappetein P, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter D, Schauerte P, Sousa Uva M, Stefanini G, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2014;35:2541–2619.
8. Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Greenberg S, Horvath SE, Iadecola C, Jauch E, Moore W, Wilson JA, on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Functional Genomics and Translational Biology, and Council on Hypertension. Guidelines for the primary prevention of stroke: a statement for healthcare 21 professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:3754–3832.
9. Boersma L, Schmidt B, Betts T, Sievert H, Tamburino C, Teiger E, Stein K, Bergmann M. EWOLUTION: design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology. Catheter Cardiovasc Interv 2016; in press.
10. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011;123: 2736–2747.
11. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011;32:205–217.
12. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the WATCHMAN left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation 2011;123:417 – 424.
13. Tzikas A, Shakir S, Gafoor S, Omran H, Berti S, Santoro G, Kefer J, Landmesser U, Nielsen-Kudsk JE, Cruz-Gonzalez I, Sievert H, Tichelbäcker T, Kanagaratnam P, Nietlispach F, Aminian A, Kasch F, Freixa X, Danna P, Rezzagh M, Vermeersch P,
14. Stock F, Stolcova M, Costa M, Ibrahim R, Schillinger W, Meier B, Park JW. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention 2015;10. doi:10.4244/ EIJY15M01_06.
15. Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H. Left atrial appendage closure with the WATCHMAN device in patients with a contraindication for oral anticoagulation. The ASAP study (ASA Plavix Feasibility Study with WATCHMAN Left Atrial Appendage Closure Technology). J Am Coll Cardiol 2013;61:2551–2556.